Emmaus Life Sciences Inc (OTCPK:EMMA)
$ 0.09204 -0.000065 (-0.07%) Market Cap: 4.94 Mil Enterprise Value: 38.77 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Emmaus Life Sciences Inc at OTC Markets Life Sciences Virtual Investor Forum Transcript

Jun 23, 2022 / 04:30PM GMT
Release Date Price: $0.37 (+15.63%)
Richard Hantke
Zacks Investment Research - Manager, IR Services

Hello, and welcome to Virtual Investor Conferences. My name is Richard Hantke. On the behalf of OTC Markets and Zacks Small-Cap Research, we're very pleased you have joined us for the Life Sciences Investor Forum.

Next presentation is from Emmaus Life Sciences. Before I introduce our speaker, a few points to note. (Conference Instructions) On a final note, all of today's presentations will be recorded and available for 24/7 replay.

At this point, I'm very pleased to welcome Dr. Yutaka Niihara, Chief Executive Officer and Chairman of the Board of Emmaus Life Sciences, which trades on the OTCQX Best Market under the symbol EMMA. Welcome, Yutaka.

Yutaka Niihara
Emmaus Life Sciences, Inc. - CEO & Chairman of the Board

Thank you, Rich. And I'd like to thank each one of you for this opportunity to present our company. At Emmaus Life Sciences, we endeavor to support and help those patients with unmet needs. Our company was founded based on our attempt to improve lives of sickle

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot